logo
Golfer says he ‘overdosed' on creatine during BMW Championship

Golfer says he ‘overdosed' on creatine during BMW Championship

CNN4 hours ago
Golf
Drugs in societyFacebookTweetLink
Follow
American golfer Ben Griffin got the shakes at the BMW Championship – though it wasn't necessarily because of nerves, but rather due to swallowing a 'large rock' of creatine.
World No. 17 Griffin said that he 'started getting super shaky' and 'felt like I had tremors' on Sunday after accidentally swallowing a large amount of the supplement.
Creatine 'contributes to rapid energy production and may enhance power or speed bursts requiring short periods of anaerobic activity,' according to Harvard Health, and usage of the supplement is common among gym enthusiasts as there is evidence it 'can hasten muscle recovery after strenuous exercise.'
'I've taken it on the golf course before. It's fine,' Griffin said, per the PGA Tour.
'I started taking it after my second shot, and I accidentally swallowed one of the big rocks in my water bottle. I've never overdosed on creatine before, but I think I did in the moment because I didn't really drink any water after that. I basically just inhaled a snowball,' the two-time PGA Tour winner explained.
Griffin said that he usually takes 15mg of the supplement daily, but on this occasion, he estimates he accidentally ingested that amount at one time.
'I was physically shaking like I've never felt before,' Griffin said. 'And I don't normally miss a lot of short putts. It was really a weird situation.'
The golfer said that his caddie intervened by making him drink water and calming him down.
Griffin was six over par for the first three holes – carding a triple-bogey, double-bogey and bogey – and the golfer thought about withdrawing from the tournament, but after that, he said the physical effects started to wear off. He then made seven birdies and signed for a one-under 69, finishing tied for 12th in an impressive comeback.
'It was probably more just a little bit flustered. I was fine after the second shot on two. And then it was – I felt good so I went about my day and got it back to under par,' he said.
The golfer said he will be limiting his intake of the supplement in future, calling the events of the day a 'pretty crazy story.'
'I don't think I'll be taking too much creatine in the future. I will take it, but not in the amount that I probably did on the golf course, which wasn't probably a healthy amount.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies

Yahoo

time27 minutes ago

  • Yahoo

Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares edged slightly higher on Tuesday. The firm's specialty pharmacy arm announced a significant expansion of its drug distribution network. The company revealed that Walgreens Specialty Pharmacy has broadened its limited distribution drug (LDD) portfolio to cover 265 therapies, strengthening its role as one of the most extensive specialty pharmacy networks in the are highly regulated medicines distributed through selected specialty pharmacies, often involving complex regimens, high costs, or special handling requirements. Unlike pharmacies linked to pharmacy benefit managers, Walgreens Specialty Pharmacy operates independently, which allows it to work flexibly with insurers, pharmaceutical manufacturers, healthcare providers, and other partners. This structure makes it possible to expand its collaborations without being restricted by direct PBM ties. 'As the limited distribution drug network continues to grow, our specialty pharmacy teams across the country are equipped to support manufacturers in getting their medications to patients who need it most,' said Tracey James, RPh, chief operating officer of Walgreens Specialty Pharmacy. She emphasized that independence helps the company engage broadly across the healthcare system. Specialty medicine has become one of the fastest-growing healthcare sectors, with roughly three-quarters of newly developed drugs falling into this category. To address these challenges, Walgreens employs a nationwide team of pharmacists, nurses, patient advocates, and insurance experts dedicated to supporting patients with unique conditions and complex treatment needs. Among the therapies added in 2025 are Yeztugo (lenacapavir) from Gilead Sciences, Inc. (NASDAQ:GILD), which is the first FDA-approved twice-yearly preventive treatment for HIV; Nemluvio (nemolizumab) from Galderma (OTC:GALDY), targeting moderate-to-severe atopic dermatitis and prurigo nodularis; and Imkeldi (imatinib) from Shorla Oncology, a therapy for certain blood cancers and related diseases. According to Benzinga Pro, WBA stock has gained over 10% in the past year. Investors can gain exposure to the stock via Invesco S&P 500 Equal Weight Consumer Staples ETF (NYSE:RSPS). Price Action: WBA stock is trading higher by 0.21% to $12.03 at last check Tuesday. Read Next: Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

I Tried Stardust and Scorpion Venom to Heal My Inflammation — Here's What Happened
I Tried Stardust and Scorpion Venom to Heal My Inflammation — Here's What Happened

Entrepreneur

time28 minutes ago

  • Entrepreneur

I Tried Stardust and Scorpion Venom to Heal My Inflammation — Here's What Happened

When I gave my TEDx talk on inflammation, I wasn't speaking as a scientist. I was speaking as someone who had lived through it. Opinions expressed by Entrepreneur contributors are their own. Eight years ago, I was diagnosed with two chronic inflammatory autoimmune conditions. The symptoms were relentless. Fatigue. Brain fog. Joint pain. Recovery that never seemed to come. I was doing everything right — or so I thought. Clean eating, quality sleep, movement, meditation. My labs improved, but my body still felt inflamed. That experience sent me deeper into the science of healing. I became certified in Culinary Medicine through Harvard. I rebuilt my nutrition from the inside out. But even with all that effort, I still needed additional support; i.e., something to lower inflammation at the cellular level. I began researching supplements. I expected to find curcumin, omega-3s and maybe magnesium. But what I didn't expect to find were two of the strangest, most powerful substances I've ever encountered. One came from outer space. The other from a scorpion. Here's what I found when I went from skeptic to bio-fangirl. Related: This Couple's 'Scrappy' Side Hustle Sold Out in 1 Weekend — It Hit $1 Million in 3 Years and Now Makes Millions Annually: 'Lean But Powerful' Carbon 60: An antioxidant that came from the stars C60, short for Carbon 60, is a molecule composed of 60 carbon atoms arranged in a perfect sphere. Discovered in the 1980s and later honored with a Nobel Prize, it was first identified in meteorites and has also been found in lightning combustion and soot particles. This molecule is regarded by researchers as one of the most powerful antioxidants ever discovered. In lab models, trace amounts of C60 dissolved in oil have been shown to minimize inflammatory markers like TNF-α from isolated human neutrophils and lower CRP levels in dogs. Additional studies show its ability to preserve muscle function and prevent free radical damage during inflammatory stress. C60 is highly reactive in raw form and must be carefully suspended in organic oils and protected from light. The product I tested from C60 Power used 99.99 percent pure sublimated C60, never exposed to solvents and was blended with certified organic oils like avocado, MCT coconut or olive oil. I took one teaspoon in the morning. Within a few days, I noticed a steady increase in energy. My brain fog started to clear. Recovery after workouts felt easier. The changes weren't extreme, but they were significant. Eventually, I added their topical serum to my skin-care routine. Alongside castor oil, it's the only thing I use on my face morning and night. The results have been visible. People stop me to ask what I'm using. I feel clearer, more radiant and glowy in a way I haven't in years. Related: What's Really Inside Your Supplements? This Founder Is Uncovering the Truth Behind a $180 Billion Industry Blue Scorpion Venom — Ancient use meets modern innovation Blue scorpion venom has been used for more than 200 years in the Caribbean as a natural remedy for inflammation and pain. In lab research, scorpion-derived peptides have shown potential for analgesic and anti-inflammatory effects. What surprised me was how this ancient remedy has been modernized. A U.S.-based biotech company, aptly named Blue Scorpion, has transformed it into a regulated, over-the-counter homeopathic solution. Manufactured in an FDA-registered facility and listed as an OTC drug, Blue Scorpion is TruShield certified for sport and tested against 471 banned substances, making it WADA and USADA approved for use by professional athletes. For everyday users, it's also eligible for HSA and FSA reimbursement. The formula includes diluted venom from the species Heteroctenus princeps, blended with Apis Mellifica and Rhus Tox. Together, these ingredients support systemic inflammation relief, nerve and muscle communication and post-exertion recovery. What sets it apart is its patented polarization process, designed to enhance bioavailability and molecular activity at the cellular level. I approached it cautiously. But to my surprise, the effects were gentle, not overwhelming. After several weeks of consistent use, I experienced decreased joint reactivity, improved digestion and a calmer nervous system. Human studies are still limited, but existing lab research and practitioner reports (via our platform, the Biohacking Index) are encouraging. More investigation is needed, but the biological rationale and early efficacy are strong. When science gets a little strange I never imagined I'd be someone using carbon molecules and venom to reduce inflammation. But when you've tried everything and still feel like something's missing, you start asking better questions. What I found in both compounds wasn't hype or magic. It was antioxidant protection, mitochondrial support and immune modulation. All grounded in real science, not trends. These tools had more regulatory oversight and clinical rationale than many popular wellness products currently flooding the market. This doesn't mean everyone should rush out and try them. It means we need to remain curious truth seekers, committed to our own health optimization journey. Join top CEOs, founders and operators at the Level Up conference to unlock strategies for scaling your business, boosting revenue and building sustainable success. Inflammation affects how we think, lead, recover and perform. For entrepreneurs, optimizing health is not a luxury; it's essential. If you're searching for anti-inflammatory support beyond the basics, stay open-minded. Stay discerning. Ask deeper questions. The future of healing may come from unexpected places. Not everything that works looks like medicine. Sometimes, it looks like stardust. Or a scorpion.

Pediatrics group's COVID-19 vaccine recommendations differ from CDC advice
Pediatrics group's COVID-19 vaccine recommendations differ from CDC advice

CBS News

time30 minutes ago

  • CBS News

Pediatrics group's COVID-19 vaccine recommendations differ from CDC advice

The American Academy of Pediatrics is sharing new vaccine recommendations that, for the first time in 30 years, differ from U.S. government advice. In the guidance published Tuesday, the AAP is "strongly recommending" COVID-19 shots for children ages 6 months to 2 years old. For older children, shots are also advised but up to parents' discretion, the AAP said. The Centers for Disease Control and Prevention's advice is different. Under Health Secretary Robert F. Kennedy Jr.'s guidance, the CDC doesn't recommend COVID-19 shots for healthy children of any age. Instead, the administration says kids may get the shots in consultation with physicians. In a news release Tuesday, AAP President Dr. Susan J. Kressly, said the organization's immunization recommendations will continue to be "rooted in science" and in the "best interest of the health of infants, children and adolescents." "Pediatricians know how important routine childhood immunizations are in keeping children, families and their communities healthy and thriving," Kressly said. Dr. Céline Gounder, CBS News medical contributor and editor-at-large for public health at KFF Health News, told "CBS Mornings Plus" on Tuesday that there's "a lot of noise out there" when it comes to vaccines. "Parents should really stick the course and make sure that their children get all of the routine childhood vaccinations," she said, adding more announcements are expected from other professional societies in the coming weeks. Gounder added AAP's recommendations are really just reaffirming what they've previously advised. "The first encounter with COVID should be with the shot, not with the virus," she said. "There is still a very high risk in younger children, particularly 6 months to 2 years, for hospitalization and severe complications if they get COVID." The AAP's recommendations also included guidance for RSV, or respiratory syncytial virus, and flu vaccines. For RSV, the APP recommends immunizations for infants younger than 8 months old who aren't protected via a vaccine from the pregnant parent, and for children 8 to 19 months old at high risk of severe infection. For the flu, the AAP recommends annual vaccines for all children starting at 6 months old, unless they have a medical reason that would prevent them from getting the vaccine. The Associated Press contributed to this report.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store